Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 Sep;107(1):262–268. doi: 10.1111/j.1476-5381.1992.tb14496.x

Cardiovascular effects of substituted tetrahydroisoquinolines in rats.

H Dong 1, C M Lee 1, W L Huang 1, S X Peng 1
PMCID: PMC1907609  PMID: 1330162

Abstract

1. A series of substituted tetrahydroisoquinolins derived from the cleavage products of tetrandrine were found to inhibit [3H]-nitrendipine binding to rat cerebral cortical membranes. Those compounds which displaced [3H]-nitrendipine binding were also able to inhibit high KCl-induced contraction of rat aorta in vitro. 2. There was a significant correlation between the ability of these tetrahydroisoquinolines to inhibit [3H]-nitrendipine binding and KCl-induced contraction (r = 0.99, P less than 0.001). 3. CPU-23 (1-(1-[(6-methoxy)-naphth-2-yl])-propyl-2-(1-piperidine)-acetyl- 6,7- dimethoxy-1,2,3,4-tetrahydroisoquinoline), one of the most potent compounds identified in this series, behaved as a simple competitive inhibitor at the [3H]-nitrendipine binding site and reduced the apparent affinity but not the maximal number of binding sites in saturation analysis. 4. In contrast to nifedipine which caused hypotension and tachycardia, CPU-23 induced both hypotension and bradycardia in a dose-dependent manner in pentobarbitone-anaesthetized Sprague-Dawley rats, spontaneously hypertensive and age-matched normotensive WKY rats. 5. It is suggested that CPU-23 may exert its cardiovascular effects via interaction with the dihydropyridine binding site on the L-type calcium channel.

Full text

PDF
262

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aoki K., Kawaguchi Y., Sato K., Kondo S., Yamamoto M. Clinical and pharmacological properties of calcium antagonists in essential hypertension in humans and spontaneously hypertensive rats. J Cardiovasc Pharmacol. 1982;4 (Suppl 3):S298–S302. [PubMed] [Google Scholar]
  3. Conti C. R., Pepine C. J., Feldman R. L., Hill J. A. Calcium antagonists. Cardiology. 1985;72(5-6):297–321. doi: 10.1159/000173886. [DOI] [PubMed] [Google Scholar]
  4. DePover A., Matlib M. A., Lee S. W., Dubé G. P., Grupp I. L., Grupp G., Schwartz A. Specific binding of [3H]nitrendipine to membranes from coronary arteries and heart in relation to pharmacological effects. Paradoxical stimulation by diltiazem. Biochem Biophys Res Commun. 1982 Sep 16;108(1):110–117. doi: 10.1016/0006-291x(82)91838-1. [DOI] [PubMed] [Google Scholar]
  5. Fang D. C., Yang X. M., Jiang M. X. Studies on the calcium antagonistic action of tetrandrine: XIII. Protective effect of tetrandrine on myocardial hypoxia and necrosis induced by isoproterenol in rats. J Tongji Med Univ. 1986;6(1):6–10. doi: 10.1007/BF02911610. [DOI] [PubMed] [Google Scholar]
  6. Fang D. C., Yao W. X., Qu L., Jiang M. X. [Effects of tetrandrine on cat papillary muscle (author's transl)]. Zhongguo Yao Li Xue Bao. 1981 Sep;2(3):163–166. [PubMed] [Google Scholar]
  7. Fleckenstein A. Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Annu Rev Pharmacol Toxicol. 1977;17:149–166. doi: 10.1146/annurev.pa.17.040177.001053. [DOI] [PubMed] [Google Scholar]
  8. Freedman D. D., Waters D. D. 'Second generation' dihydropyridine calcium antagonists. Greater vascular selectivity and some unique applications. Drugs. 1987 Nov;34(5):578–598. doi: 10.2165/00003495-198734050-00005. [DOI] [PubMed] [Google Scholar]
  9. Gould R. J., Murphy K. M., Snyder S. H. [3H]nitrendipine-labeled calcium channels discriminate inorganic calcium agonists and antagonists. Proc Natl Acad Sci U S A. 1982 Jun;79(11):3656–3660. doi: 10.1073/pnas.79.11.3656. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hu W. S., Pang X. B., Wang Y., Hu C. J., Lü F. H. Mode of action of tetrandrine on vascular smooth muscle. J Tradit Chin Med. 1983 Mar;3(1):7–12. [PubMed] [Google Scholar]
  11. Huang W. L., Song X. Q., Peng S. X., Huang Z. Y. [The synthesis and biological activity of substituted tetrahydroisoquinoline compounds]. Yao Xue Xue Bao. 1990;25(11):815–823. [PubMed] [Google Scholar]
  12. Inubushi Y., Masaki Y., Matsumoto S., Takami F. Studies on the alkaloids of menispermaceous plants. CCXLIX. Total synthesis of optically active natural isotetrandrine, phaeanthine, and tetrandrine. J Chem Soc Perkin 1. 1969 Jun;11:1547–1556. doi: 10.1039/j39690001547. [DOI] [PubMed] [Google Scholar]
  13. Kawashima K., Hayakawa T., Miwa Y., Oohata H., Suzuki T., Fujimoto K., Ogino T., Chen Z. X. Structure and hypotensive activity relationships of tetrandrine derivatives in stroke-prone spontaneously hypertensive rats. Gen Pharmacol. 1990;21(3):343–347. doi: 10.1016/0306-3623(90)90835-a. [DOI] [PubMed] [Google Scholar]
  14. King V. F., Garcia M. L., Himmel D., Reuben J. P., Lam Y. K., Pan J. X., Han G. Q., Kaczorowski G. J. Interaction of tetrandrine with slowly inactivating calcium channels. Characterization of calcium channel modulation by an alkaloid of Chinese medicinal herb origin. J Biol Chem. 1988 Feb 15;263(5):2238–2244. [PubMed] [Google Scholar]
  15. Kong Y. C., Lee C. M., Wong M. K., Xu S. B. Smooth muscle relaxant effect of dehydroindicolactone. Gen Pharmacol. 1986;17(5):593–595. doi: 10.1016/0306-3623(86)90101-1. [DOI] [PubMed] [Google Scholar]
  16. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  17. Murphy K. M., Gould R. J., Largent B. L., Snyder S. H. A unitary mechanism of calcium antagonist drug action. Proc Natl Acad Sci U S A. 1983 Feb;80(3):860–864. doi: 10.1073/pnas.80.3.860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ohtsuka M., Yokota M., Kodama I., Yamada K., Shibata S. New generation dihydropyridine calcium entry blockers: in search of greater selectivity for one tissue subtype. Gen Pharmacol. 1989;20(5):539–556. doi: 10.1016/0306-3623(89)90084-0. [DOI] [PubMed] [Google Scholar]
  19. Qian J. Q., Thoolen M. J., van Meel J. C., Timmermans P. B., van Zwieten P. A. Hypotensive activity of tetrandrine in rats. Investigation into its mode of action. Pharmacology. 1983;26(4):187–197. doi: 10.1159/000137801. [DOI] [PubMed] [Google Scholar]
  20. Spedding M., DiFrancesco G. F., Mir A. K., Petty M. A., Berg C., Gittos M. MDL 72567, a dihydropyridine calcium-antagonist, that causes vasodilation and direct sinus bradycardia. J Cardiovasc Pharmacol. 1987 Jul;10(1):62–71. doi: 10.1097/00005344-198707000-00009. [DOI] [PubMed] [Google Scholar]
  21. Todd G. L., Sterns D. A., Plambeck R. D., Joekel C. S., Eliot R. S. Protective effects of slow channel calcium antagonists on noradrenaline induced myocardial necrosis. Cardiovasc Res. 1986 Sep;20(9):645–651. doi: 10.1093/cvr/20.9.645. [DOI] [PubMed] [Google Scholar]
  22. Wang G., Zong X. G., Fang D. C., Jiang M. X., Lu F. H. [Effects of tetrandrine on the slow inward currents in canine cardiac Purkinje fibers]. Yao Xue Xue Bao. 1988;23(9):646–650. [PubMed] [Google Scholar]
  23. Yao W. X., Xia G. J., Fang D. C., Jiang M. X. [Effects of tetrandrine, verapamil and propranolol on contractility and cAMP level of isolated rabbit left atria]. Zhongguo Yao Li Xue Bao. 1983 Mar;4(1):29–32. [PubMed] [Google Scholar]
  24. Zheng X. F., Bian R. L. [Effects of tetrandrine on KCl-, CaCl2- and norepinephrine-induced contractions of isolated rabbit main pulmonary arteries]. Zhongguo Yao Li Xue Bao. 1986 Jan;7(1):40–43. [PubMed] [Google Scholar]
  25. Zong X. G., Jin M. W., Xia G. J., Fang D. C., Jiang M. X. [Effects of tetrandrine on action potential and contraction of isolated guinea pig papillary muscle]. Zhongguo Yao Li Xue Bao. 1983 Dec;4(4):258–261. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES